Well I have my final visit yet to do but phase 1a at the end announced 1 hR ago per my linked in feed.
poking for funding for next phase it appears:
‘Completion of first part of OVM-200 clinical trial
Oxford Vacmedix announces the successful completion of Phase 1a in the Phase 1 safety trial of cancer vaccine OVM-200, being used to treat ovarian cancer, prostate cancer and lung cancer
This trial is also the first clinical trial of the ground breaking ROP (recombinant overlapping peptide) technology invented by Professor Shisong Jiang, in the Department of Oncology at the University of Oxford’